Hypnotherapy for irritable bowel syndrome in Saudi Arabian patients

Eastern Mediterranean Health Journal

Volumn 13, Issue 2, 2007, Pages 301-308

  Al Sughayir, M A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROENTEROLOGY; HUMAN; HYPNOSIS; IRRITABLE COLON; MALE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT SATISFACTION; QUALITY OF LIFE; RATING SCALE; SAUDI ARABIA; SEX DIFFERENCE; SYMPTOM; TREATMENT DURATION;

ABDOMINAL PAIN; ATTITUDE TO HEALTH; CHI-SQUARE DISTRIBUTION; DEFECATION; FEMALE; HUMANS; HYPNOSIS; IRRITABLE BOWEL SYNDROME; MALE; QUALITY OF LIFE; QUESTIONNAIRES; SAUDI ARABIA; SELF CARE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34447255667     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Thompson WG. Irritable bowel syndrome: prevalence, prognosis and consequences. Canadian Medical Association journal, 1986:134:111-3.
2. Thompson WG et al. Irritable bowel syndrome: The view from general practice. European journal of gastroenterology & hepatology, 1997, 9:689-92.
3. Switz DM. What the gastroenterologist does all day. A survey of a state society's practice. Gastroenterology, 1976, 70:1048-50.
4. Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology out-patients. Lancet, 1983, 1:632-4.
5. Akehurts RL. Burden of illness of irritable bowel syndrome. An interim report on behalf of Novartis Pharma AG, Basel, Switzerland. Sheffield, School of Health and Related Research, University of Sheffield, 1999.
6. Kingham JC, Dawson AM. Origin of chronic right upper quadrant pain. Gut, 1985, 26:783-8.
7. Gralnek IM et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology, 2000, 119:655-60.
8. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet, 1984, 2:1232-4.
9. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut, 1987, 28:423-5.
10. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. American journal of gastroenterology, 2002, 97:954-61.
11. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy. Alimentary pharmacology & therapeutics, 1996, 10:91-5.
12. Lea R. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Alimentary pharmacology and therapeutics, 2003, 17:635.
13. Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut, 1990, 31:896-898.
14. Vidakovic-Vukic M. Hypnotherapy in the treatment of irritable bowel syndrome: methods and results from Amsterdam. Scandinavian journal of gastroenterology, 1999, 230 (Suppl.):49-51.
15. Palsson OS, Burnett CK, Meyer K, Whitehead WE. Hypnosis treatment for irritable bowel syndrome. Effects on symptoms pain threshold and muscle tone [abstract]. Gastroenterology, 1997, 112:A803.
16. Palsson OS, Turner MJ, Johnson DA. Hypnotherapy for irritable bowel syndrome: symptom improvement and autonomic nervous system effects [abstract]. Gastroenterology, 2000, 118:A174.
17. Zimmerman J. Assessment of the response to hypnotherapy in functional bowel disorders (FBD). Gastroenterology, 1999, 116(4):A1108/G4805.
18. Fathy D et al. Psychological aspects of irritable bowel syndrome. Egyptian journal of psychiatry, 1990 13:259-69.
19. Fadil K. Psychopathology of irritable bowel syndrome among Arab patients in Qatar. Arab journal of psychiatry, 1991, 2(1):53-63.
20. Farsakh N et al. Epidemiology of colonic symptoms and irritable bowel syndrome in the general population of Jordan. Saudi medical journal, 1998, 19(6):688-92.
21. Haggag W et al. Objective psychiatric assessment of a sample of patients with irritable bowel syndrome. Current psychiatry, 2000, 7(2):225-35.
22. Mohammed A, Ghandour Z, Alkarawi M. Spasmocanulase in irritable bowel syndrome. Saudi medical journal, 2002, 23(9): 1074-7.
23. Thompson WG et al. Functional bowel disease and functional abdominal pain. Gut, 1999, 45(Suppl. 2):1143-7.
24. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary pharmacology & therapeutics, 1997, 11:395-402.
25. Whorwell PJ. Use of hypnotherapy in gastrointestinal disease. British journal of hospital medicine, 1991,45:27-9.
26. Trancework. In: Yapko M, ed. An introduction to the practice of clinical hypnosis, 2nd ed. New York, Brunner/Mazel, 1990.
27. Houghton LA et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Alimentary pharmacology & therapeutics, 2003:17:635-42.
28. Taché Y et al. Stress and the gastroenterology tract III. Stress-related alterations of gut motor functions: role of brain-corticotropin-releasing factor receptors. American journal of physiology. Gastrointestinal and liver physiology, 2001,280:G173-7.
29. Drossman DA et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology, 2003, 124:754-61.
30. Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut, 2002, 51:167-71.
31. Gonsalkorale WM et al. Long-term benefits of hypnotherapy for irritable bowel syndrome. Gut, 2003, 52:1623-9.
32. Harvey RF et al. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet, 1989, 25:424-5.